|
08 Jul 2020 |
Merck and Eisai Receive Complete Response Letter for KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination as First-Line Treatment for Unresectable Hepatocellular Carcinoma
|
|
08 Jul 2020 |
Aclaris Therapeutics Submits Investigational New Drug Application for ATI-1777, a Topical “Soft” JAK1/3 Inhibitor, for the Treatment of Moderate to Severe Atopic Dermatitis
|
|
08 Jul 2020 |
NextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid Tumors
|
|
08 Jul 2020 |
Evive Biotech meets primary and secondary endpoints in global Phase III clinical trial for their novel chemotherapy-induced neutropenia treatment
|
|
08 Jul 2020 |
CEPI Expands Partnership with Clover Biopharmaceuticals to Rapidly Advance Development and Manufacture of COVID-19 Vaccine Candidate
|
|
08 Jul 2020 |
Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer
|
|
08 Jul 2020 |
Otsuka announces simultaneous regulatory approvals by U.S. FDA and Health Canada of INQOVI®, an oral hypomethylating agent (HMA) therapy for MDS and CMML
|
|
08 Jul 2020 |
Novavax Announces $1.6 Billion Funding from Operation Warp Speed
|
|
08 Jul 2020 |
Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential deal value of €875 million, plus royalties
|
|
07 Jul 2020 |
Cyteir Therapeutics Advances Clinical Trial of Lead RAD51 Synthetic Lethality Program in Cancer and Expands Senior Leadership Team
|
|
07 Jul 2020 |
ViiV Healthcare Announces Superior Efficacy of Investigational, Long-Acting Injectable Formulation of Cabotegravir Dosed Every Two Months Over Daily Oral PrEP
|
|
07 Jul 2020 |
Tau-PET Tracer PI-2620 Could Set New Standards for an Improved Diagnosis of Progressive Supranuclear Palsy
|
|
07 Jul 2020 |
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
|
|
07 Jul 2020 |
Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases
|
|
07 Jul 2020 |
Curis Doses First Patient in Phase 1 Study of CA-4948 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
|
07 Jul 2020 |
Celixir provides update on ongoing clinical programme with lead therapeutic candidate CLXR-001
|
|
07 Jul 2020 |
Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-313 in Patients with Tinnitus
|
|
07 Jul 2020 |
Johns Hopkins Reports Promising Clinical Data in COVID-19 ARDS Treated with Cellenkos' Cord Blood T-Regulatory Cells
|
|
07 Jul 2020 |
In Fight Against COVID-19, CSL Behring Begins Trial to Evaluate Monoclonal Antibody (CSL312) for Respiratory Distress
|
|
07 Jul 2020 |
Unum Therapeutics Inc. Announces Acquisition of Kiq LLC
|
